Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ · Healthcare
Zentalis Pharmaceuticals, Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 0 | 67.4M | 0 | 0 |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | -152.8M | -191.2M | -299.5M | -227.3M |
| EBITDA | — | — | — | — |
| Net Income | -137.1M | -165.8M | -292.2M | -236.8M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 72M | 71M | 65M | 53M |
Zentalis Pharmaceuticals, Inc. Income Statement — FAQ
Zentalis Pharmaceuticals, Inc. (ZNTL) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZNTL's income statement history?
The chart and table above show Zentalis Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.